We bring you the latest updates from Dark Daily through a simple and fast subscription.
We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.
Unsubscribe at any time without hassle.
Dark Daily's title: DARK Daily Laboratory and Pathology News
Is this your feed? Claim it!
What the VA’s New Baylor Genetics Contract Means for Clinical Lab Leaders. For clinical laboratory leaders tracking the growing role of precision medicine in federal healthcare systems, the US Department of Veterans Affairs (VA) has taken another significant step toward broad genomic integration. Baylor Genetics announced it has been awarded a multi-year national contract to ...
Teen researchers in suburban Atlanta may have cracked one of diagnostics’ toughest challenges: early Lyme detection. Their CRISPR test shows promise for identifying infection long before standard tools can. For laboratory leaders navigating a rapidly shifting diagnostics landscape, a new signal of future innovation is emerging from an unexpected place: a suburban high school ...
A new open-source platform enhances the interpretability of CBC-based machine-learning models for sepsis prediction, offering improved transparency and clinical utility. Laboratory leaders watching the evolution of clinical AI tools now have a new development to track: a fully open-source web application designed to make machine-learning–based sepsis prediction more interpret...
New ranking highlights the pathologists with the biggest social media reach—and what their influence means for diagnostics, research, and industry engagement. A new analysis identifies the most influential US pathologists on Twitter/X, highlighting a growing link between social media reach and clinical impact. The ranking, based on follower counts, spotlights pathologists who...
With 300,000 men expected to enroll, researchers hope the trial will redefine prostate cancer screening and reduce preventable late-stage disease. The UK has launched the £42 million Transform trial, the largest prostate cancer screening study in decades—marking a defining moment for pathology and laboratory leaders tracking the future of population-level diagnostics. Designe...
